Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

SARS-CoV-2, the virus responsible for Covid-19, has not disappeared, but it no longer behaves like an unpredictable emergency ...

India is experiencing a surge in Covid-19 cases, primarily driven by the JN.1 Omicron sub-variant, prompting increased ...

Researchers discovered that COVID-19 and chronic hepatitis B share key genetic pathways related to the immune system. This ...

Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.

FDA officials outlined new restrictions for COVID-19 vaccines that could limit their use in the United States.

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA ...

Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert ...

Health officials in Hong Kong and Singapore have once again issued a warning about a sharp surge in COVID-19 cases in the coming days, which could potentially trigger another pandemic.

GSK Plc agreed to buy an experimental medicine for as much as $2 billion to shore up its drug pipeline and muscle into the promising field of liver therapies. The treatment is ready to enter the last ...

Participants got two liver biopsies to help evaluate the effects of semaglutide. About 56% of participants had type 2 diabetes, and about 73% had obesity. The researchers evaluated participants ...